Indirect Coombs Test

INDIRECT COOMBS TEST Test

The Indirect Coombs Test, also called the Indirect Antiglobulin Test (IAT), detects antibodies in the blood that can bind to specific antigens on red blood cells. These antibodies may develop after blood transfusion, pregnancy, or exposure to different red blood cell antigens.

The test is commonly performed before blood transfusion to identify unexpected antibodies and help select compatible blood. It is also an important test during pregnancy, particularly when there is a risk of maternal antibodies reacting with the baby's red blood cells.

By identifying clinically significant red-cell antibodies, the test helps healthcare professionals reduce the risk of transfusion reactions and assess the possibility of hemolytic disease of the fetus and newborn (HDFN).

This Test is Recommended for Individuals:

• Undergoing pre-transfusion testing
• Preparing for a blood transfusion or certain blood-related procedures
• Pregnant individuals undergoing antenatal blood group and antibody screening
• With a history of previous blood transfusions
• With a history of pregnancy where red-cell antibody incompatibility may be a concern
• Previously identified with an unexpected red blood cell antibody
• Requiring evaluation of blood compatibility before transfusion

FAQs

1. What is the Indirect Coombs Test used for?
The Indirect Coombs Test detects antibodies present in the patient's blood plasma or serum that may react with red blood cells. It is commonly used for blood compatibility testing and antenatal antibody screening.

2. What does a positive Indirect Coombs Test mean?
A positive result means that antibodies capable of reacting with red blood cell antigens have been detected. Further antibody identification may be required to determine the specific antibody and its clinical significance.

3. Why is the Indirect Coombs Test done during pregnancy?
During pregnancy, the test can identify maternal red blood cell antibodies that may cross the placenta and potentially affect the baby's red blood cells. Early identification allows appropriate monitoring and management when necessary.